NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe Patent allowance strengthens IP portfolio and positions company in pursuing drug delivery using its neural probes EDEN PRAIRIE, Minn., Nov. 16, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical...

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System Feedback from responses to FDA anticipated in 30 days Commercialization remains on track in first half of 2024 pending FDA clearance Product potential for transformative improvement in...

NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14 EDEN PRAIRIE, Minn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...

St. Paul Surgeons to Join HealthEast ST. PAUL, MN--(Marketwired - May 29, 2014) - HealthEast is pleased to announce a new era in surgical care at our hospitals, clinics and outpatient surgical facilities. Beginning July 1, the...